Michael David Barker

Person

Stevenage, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Benzoimidazole derivatives as PAD4 inhibitors
- Patent number 10,815,218
- Issue date Oct 27, 2020
- GlaxoSmithKline Intellectual Property Development Limited
- Dominique Amans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzoimidazole derivatives as PAD4 inhibitors
- Patent number 10,407,407
- Issue date Sep 10, 2019
- GlaxoSmithKline Intellectual Property Development Limited
- Dominique Amans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
- Patent number 10,039,755
- Issue date Aug 7, 2018
- Glaxo Group Limited
- Stephen John Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors
- Patent number 9,833,449
- Issue date Dec 5, 2017
- Glaxo Group Limited
- Stephen John Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Furopyridines as bromodomain inhibitors
- Patent number 9,670,221
- Issue date Jun 6, 2017
- GlaxoSmithKline Intellectual Property (No. 2) Limited
- Dominique Amans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors
- Patent number 9,518,054
- Issue date Dec 13, 2016
- Glaxo Group Limited
- Stephen John Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds
- Patent number 9,447,074
- Issue date Sep 20, 2016
- Glaxo Group Limited
- Francis Louis Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors
- Patent number 9,127,003
- Issue date Sep 8, 2015
- Glaxo Group Limited
- Stephen John Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds
- Patent number 8,993,560
- Issue date Mar 31, 2015
- Glaxo Group Limited
- Francis Louis Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors
- Patent number 8,633,319
- Issue date Jan 21, 2014
- Glaxo Group Limited
- Francis Louis Atkinson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Purine derivatives as agonists of the adenosine A2A receptor
- Patent number 7,985,740
- Issue date Jul 26, 2011
- Glaxo Group Limited
- David George Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline derivatives as phosphodiesterase inhibitors
- Patent number 7,572,915
- Issue date Aug 11, 2009
- Glaxo Group Limited
- Michael David Barker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline derivatives as phosphodiesterase inhibitors
- Patent number 7,566,786
- Issue date Jul 28, 2009
- Glaxo Group Limited
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
- Patent number 6,528,494
- Issue date Mar 4, 2003
- Brian Cox
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
- Patent number 6,426,337
- Issue date Jul 30, 2002
- SmithKline Beecham Corporation
- Brian Cox
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS
- Publication number 20200095227
- Publication date Mar 26, 2020
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
- Dominique Amans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS
- Publication number 20180297983
- Publication date Oct 18, 2018
- GlaxoSmithKline Intellectual Property Development Limited
- Dominique Amans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS
- Publication number 20180161316
- Publication date Jun 14, 2018
- Glaxo Group Limited
- Stephen John Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS
- Publication number 20170119750
- Publication date May 4, 2017
- Glaxo Group Limited
- Stephen John Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20160355505
- Publication date Dec 8, 2016
- Glaxo Group Limited
- Francis Louis ATKINSON
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUROPYRIDINES AS BROMODOMAIN INHIBITORS
- Publication number 20160016966
- Publication date Jan 21, 2016
- GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
- Dominique AMANS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2 - (AZAINDOL-2-YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS
- Publication number 20160009716
- Publication date Jan 14, 2016
- Glaxo Group Limited
- Stephen John Atkinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS
- Publication number 20150175600
- Publication date Jun 25, 2015
- Glaxo Group Limited a corporation
- Stephen John Atkinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20150166508
- Publication date Jun 18, 2015
- Glaxo Group Limited
- Francis Louis Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS
- Publication number 20140005188
- Publication date Jan 2, 2014
- Glaxo Group Limited
- Francis Louis Atkinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIB...
- Publication number 20140005177
- Publication date Jan 2, 2014
- Glaxo Group Limited
- Francis Louis Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS
- Publication number 20130040984
- Publication date Feb 14, 2013
- Glaxo Group Limited
- Francis Louis Atkinson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20120232061
- Publication date Sep 13, 2012
- Glaxo Group Limited
- Francis Louis Atkinson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR...
- Publication number 20100179139
- Publication date Jul 15, 2010
- Paul Bamborough
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INH...
- Publication number 20100035917
- Publication date Feb 11, 2010
- Paul Bamborough
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline Derivatives As Phosphodiesterase Inhibitors
- Publication number 20090312325
- Publication date Dec 17, 2009
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Purine Derivatives as Agonists of the Adenosine A2a Receptor
- Publication number 20080214581
- Publication date Sep 4, 2008
- David George Allen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phenyl-Pyrazole Derivatives as Non-Steroidal Glucocorticoid Recepto...
- Publication number 20080207725
- Publication date Aug 28, 2008
- Glaxo Group Limited, a Corporation
- Michael David Barker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20080176891
- Publication date Jul 24, 2008
- Paul Bamborough
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20080146606
- Publication date Jun 19, 2008
- Paul Bamborough
- C07 - ORGANIC CHEMISTRY
Information Patent Application
P38 kinase inhibitors
- Publication number 20070161673
- Publication date Jul 12, 2007
- Michael David Barker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline derivatives as phosphodiesterase inhibitors
- Publication number 20070142373
- Publication date Jun 21, 2007
- Ian Robert Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinoline derivatives as phosphodiesterase inhibitors
- Publication number 20060178416
- Publication date Aug 10, 2006
- Michael David Barker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
- Publication number 20020086850
- Publication date Jul 4, 2002
- Brian Cox
- C07 - ORGANIC CHEMISTRY

Michael David Barker

Person

Patents Grantslast 30 patents

Benzoimidazole derivatives as PAD4 inhibitors

Benzoimidazole derivatives as PAD4 inhibitors

2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors

2-(azaindol-2-yl) benzimidazoles as PAD4 inhibitors

Furopyridines as bromodomain inhibitors

2-(azaindol-2-yl) benz imidazoles as PAD4 inhibitors

Compounds

2-(azaindol-2-yl)benzimidazoles as PAD4 inhibitors

Compounds

7-(1H-pyrazol-4-yl)-1,6-naphthyridine compounds as Syk inhibitors

Purine derivatives as agonists of the adenosine A2A receptor

Quinoline derivatives as phosphodiesterase inhibitors

Quinoline derivatives as phosphodiesterase inhibitors

2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives

2-(Purin-9-yl)-tetrahydrofuran-3,4-diol derivatives

Patents Applicationslast 30 patents

BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS

BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS

2-(AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS

2- (AZAINDOL-2-YL) BENZIMIDAZOLES AS PAD4 INHIBITORS

NOVEL COMPOUNDS

FUROPYRIDINES AS BROMODOMAIN INHIBITORS

2 - (AZAINDOL-2-YL) BENZ IMIDAZOLES AS PAD4 INHIBITORS

2-(AZAINDOL-2-YL)BENZIMIDAZOLES AS PAD4 INHIBITORS

NOVEL COMPOUNDS

PYRIDO[3,4-B]PYRAZINE DERIVATIVES AS SYK INHIBITORS

PYRIDINYL- AND PYRAZINYL-METHYLOXY-ARYL DERIVATIVES USEFUL AS INHIB...

7-(lH-PYRAZOL-4-YL)-1,6-NAPHTHYRIDINE COMPOUNDS AS SYK INHIBITORS

NOVEL COMPOUNDS

PYRROLOPYRIDINE COMPOUNDS, PROCESS FOR THEIR PREPARATION, AND THEIR...

PYRROLO[2,3-B]PYRIDIN-4-YL-BENZENESULFONAMIDE COMPOUNDS AS 1KK2 INH...

Quinoline Derivatives As Phosphodiesterase Inhibitors

Purine Derivatives as Agonists of the Adenosine A2a Receptor

Phenyl-Pyrazole Derivatives as Non-Steroidal Glucocorticoid Recepto...

NOVEL COMPOUNDS

NOVEL COMPOUNDS

P38 kinase inhibitors

Quinoline derivatives as phosphodiesterase inhibitors

Quinoline derivatives as phosphodiesterase inhibitors

2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives